Literature DB >> 98212

Multiple sclerosis: oligoclonal IgG, kappa-lambda light chain distribution and measles antibodies in brain extracts.

F Bollengier, A Mahler, G Clinet, A Lowenthal.   

Abstract

The presence of measles antibodies in white and grey brain material and in 8 demyelination plaques from 6 patients affected with multiple sclerosis was investigated with the hemagglutination inhibition (HI) and complement fixation (CF) techniques. White and grey matter of 5 controls were run in parallel. No measles antibodies could be detected, except for one plaque, where the answer could be considered as doubtful. The immunoglobulin G (IgG) content and the kappa/lambda light chain ratios of all the samples were evaluated. No unique monoclonal immunoglobulin population could be detected, but kappa or lambda predominant oligoclonal populations appeared in controls as well as in MS IgG.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 98212     DOI: 10.1016/0006-8993(78)90139-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Determination of CSF proteins by a simple and rapid immunonephelometric method.

Authors:  K G Kjellin; L B Hallander
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

2.  Measles antibodies, kappa-lambda light chain distribution and immunoglobulins in serum, cerebrospinal fluid and brain of a patient affected with multiple sclerosis.

Authors:  F Bollengier; A Mahler; G Clinet
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

3.  Measles antibodies and kappa-lambda light chain distribution in immunoglobulins of patients affected with multiple sclerosis.

Authors:  F Bollengier; A Mahler
Journal:  J Neurol       Date:  1979-03-22       Impact factor: 4.849

4.  Antibody to myelin basic protein in extracts of multiple sclerosis brain.

Authors:  C C Bernard; V B Randell; L B Horvath; P R Carnegie; I R Mackay
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.